AJKD: Survival rate and prognosis of patients with systemic lupus erythematosus after renal replacement therapy

Systemic lupus erythematosus (SLE) is a different organ systems involved itself immune diseases

Immune lupus nephritis (LN) is one of the most common and important organ involvement types in SLE, which has a negative impact on the prognosis of patients

The purpose of this study was to describe the trends in the incidence and prevalence of KRT in these patients, and to compare the results with patients with diseases other than SLE who received KRT

A total of 1826 patients started KRT due to renal failure caused by systemic lupus erythematosus (SLE), with an annual incidence of 0.

The survival rate of SLE patients treated with KRT was similar to that of the control group

The incidence of renal replacement therapy (KRT) in the treatment of systemic renal failure

The incidence of renal replacement therapy (KRT) in the treatment of systemic renal failure

The 10-year overall survival rate of patients treated with KRT, as well as the survival rate of patients and grafts after kidney transplantation, improved during the study period

The 10-year overall survival rate of patients treated with KRT, as well as the survival rate of patients and grafts after kidney transplantation, improved during the study period

Kaplan-Meier survival analysis, comparing (A) patients' survival on the first day after renal replacement therapy (KRT), and (B) patients and (C) after the first kidney transplantation in 1992-2006, SLE patients and matched patients Kidney transplant survival rate in the control group

Kaplan-Meier survival analysis, comparing (A) patients' survival on the first day after renal replacement therapy (KRT), and (B) patients and (C) after the first kidney transplantation in 1992-2006, SLE patients and matched patients Kidney transplant survival rate in the control group

In short, in this large European cohort, the incidence of KRT in renal failure caused by SLE has plateaued

In short, in this large European cohort, the incidence of KRT in renal failure caused by SLE has plateaued

 References: Ondrej Derner, Anneke Kramer, Zdenka Hruskova, et al, Incidence of Kidney Replacement Therapy and Subsequent Outcomes Among Patients With Systemic Lupus Erythematosus: Findings From the ERA Registry, American Journal of Kidney Diseases, 2021, ISSN 0272-6386, https ://doi.
org/10.
1053/j.
ajkd.
2021.
09.
016.
https://doi.
org/10.
1053/j.
ajkd.
2021.
09.
016.


Leave a message here